drugset

drugset / Trial / NCT07161843

Use of QRX3 for Acute Tubular Necrosis Type of Renal Failure in Hospitalized Patients ( QRX-3 in ARF)

NCT07161843 ↗

Phase 2/3 Not yet recruiting 500 enrolled Ebima Clifford Okundaye

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Use of QRX-3 in hospitalized patients with pediatric and adult patients with acute tubular necrosis renal failure

Timeline

Start: 2026-06-30
Primary completion: 2026-12-30
Completion: 2027-02-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	QRX-3	Unknown	—	Oral

Indications